A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout | MicrobiomeTrials
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-02-09Est. Completion: 2028-06-18
Enrollment target: 270 participants
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
Orthopedic Physicians Alaska, Anchorage, Alaska, United States
Unity Health Searcy Medical Center, Searcy, Arkansas, United States
Precision Rheumatology, Anaheim, California, United States
Advanced Clinical Research Center, LLC dba TriWest Research Associates, Chula Vista, California, United States
Veterans Affairs Long Beach Health Care System, Long Beach, California, United States
Solace Clinical Research, Tustin, California, United States
Jiva Health, Walnut Creek, California, United States
Denver Arthritis Clinic PC, Denver, Colorado, United States
Arthritis and Rheumatic Disease Specialties, Aventura, Florida, United States
D and H Pompano Research Center, Aventura, Florida, United States
Bay Pines Veterans Affairs Healthcare System, Bay Pines, Florida, United States
Discovery Health Research Center, Coral Springs, Florida, United States
Hillcrest Medical Research, DeLand, Florida, United States
New Generation of Medical Research, Hialeah, Florida, United States
Other microbiome trials you might be interested in